Gergen Mark J
- SEC CIK
- 0001373110
No open-market purchases or sales filed in the past year.
Current role at each company
- PSTX Poseida Therapeutics, Inc.President and CEOas of Jan 8, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gergen Mark J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2024 (view filing) | Dec 10 | 1 day | Gergen Mark JExecutive Chairman | SSale | −30.0K | $9.46 | −$283.8K | −4.4%651.3K after | 10b5-1 |
| Nov 27, 2024 (view filing) | Nov 26 | 1 day | Gergen Mark JExecutive Chairman | SSale | −30.0K | $9.27 | −$278.1K | −4.4%651.3K after | 10b5-1 |